Your browser doesn't support javascript.
loading
Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia.
Pharaoh, Gavin; Brown, Jacob L; Sataranatarajan, Kavithalakshmi; Kneis, Parker; Bian, Jan; Ranjit, Rojina; Hadad, Niran; Georgescu, Constantin; Rabinovitch, Peter; Ran, Qitao; Wren, Jonathan D; Freeman, Willard; Kinter, Michael; Richardson, Arlan; Van Remmen, Holly.
Afiliação
  • Pharaoh G; Physiology Department, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Brown JL; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Sataranatarajan K; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Kneis P; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Bian J; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Ranjit R; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Hadad N; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Georgescu C; Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Rabinovitch P; Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Ran Q; Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Wren JD; Department of Pathology, University of Washington, Seattle, WA, USA.
  • Freeman W; Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX, USA.
  • Kinter M; South Texas Veterans Health Care System, San Antonio, TX, USA.
  • Richardson A; Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Van Remmen H; Physiology Department, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Sci Rep ; 10(1): 13968, 2020 08 18.
Article em En | MEDLINE | ID: mdl-32811851
ABSTRACT
Defects in neuromuscular innervation contribute significantly to the age-related decline in muscle mass and function (sarcopenia). Our previous studies demonstrated that denervation induces muscle mitochondrial hydroperoxide production (H2O2 and lipid hydroperoxides (LOOHs)). Here we define the relative contribution of mitochondrial electron transport chain (ETC) derived H2O2 versus cytosolic phospholipase A2 (cPLA2) derived LOOHs in neurogenic muscle atrophy. We show that denervation increases muscle cPLA2 protein content, activity, and metabolites downstream of cPLA2 including LOOHs. Increased scavenging of mitochondrial H2O2 does not protect against denervation atrophy, suggesting ETC generated H2O2 is not a critical player. In contrast, inhibition of cPLA2 in vivo mitigates LOOH production and muscle atrophy and maintains individual muscle fiber size while decreasing oxidative damage. Overall, we show that loss of innervation in several muscle atrophy models including aging induces generation of LOOHs produced by arachidonic acid metabolism in the cPLA2 pathway contributing to loss of muscle mass.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfolipases A2 / Sarcopenia / Peróxidos Lipídicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfolipases A2 / Sarcopenia / Peróxidos Lipídicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article